Target- |
MechanismImmunostimulants |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Nant Africa LLC
0 Patents (Medical) associated with Nant Africa LLC
100 Deals associated with Nant Africa LLC
100 Translational Medicine associated with Nant Africa LLC